Intranasal Oxytocin for Frontotemporal Dementia
Summary
- Eligibility
- for people ages 30-80 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Adam Boxer
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Adam Boxer
Adam L. Boxer, MD, PhD is Endowed Professor in Memory and Aging in the Department of Neurology at the University of California, San Francisco (UCSF). He directs UCSF’s Neurosciences Clinical Research Unit and the Alzheimer’s Disease and Frontotemporal Degeneration (FTD) Clinical Trials Program at the UCSF Memory and Aging Center.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Lawson Health Research Institute
- ID
- NCT03260920
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated